Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Otsuka Pharmaceutical Completes First Construction Stage Of Tianjin Project

This article was originally published in PharmAsia News

Executive Summary

China Otsuka Pharmaceutical has recently completed stage one construction of its phase two project in Tianjin and is pressing ahead with equipment installation and testing. The production facility is scheduled to formally start operation in early 2009 and will help boost the economy of the Xiqing district. With total investment of RMB 400 million, the phase two project is designed for an annual output of 30 million soft bags and 30 million plastic bottles for transfusion. The revenue is expected to reach more than RMB 300 million when the plant is fully operational. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069296

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel